Researcher

Sir David Lane is credited with the landmark discovery of p53 and its role in cancer development. As the Chief Scientist of A*STAR, Lane advises and engages in scientific development across the Biomedical Research Council (BMRC) and the Scientific Engineering Research Council (SERC) at the strategic level. Lane is concurrently the Director of the p53 Laboratory, which primarily focuses on research on protein interactions and how to develop drugs to inhibit such interactions, using p53 as a model system.